Evaluation of Treatment Benefit: Randomized Controlled Trials and Population-Based Observational Research

被引：22
作者：
Booth, Christopher M. [1 ]
Tannock, Ian F. [2 ,3 ]
机构：
[1] Queens Univ, Canc Res Inst, Kingston, ON, Canada
[2] Princess Margaret Canc Ctr, Toronto, ON, Canada
[3] Univ Toronto, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 26期
关键词：
ADJUVANT CHEMOTHERAPY; SYSTEMIC THERAPY; BREAST; INITIATION; SURGERY; DISEASE; WOMEN;
D O I：
10.1200/JCO.2013.51.5023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3298 / 3299
页数：2
相关论文
共 12 条
[1]   Discordance Between Conclusions Stated in the Abstract and Conclusions in the Article: Analysis of Published Randomized Controlled Trials of Systemic Therapy in Lung Cancer [J].
Altwairgi, Abdullah K. ;
Booth, Christopher M. ;
Hopman, Wilma M. ;
Baetz, Tara D. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (28) :3552-3557
[2]   Surgeon volume and operative mortality in the United States [J].
Birkmeyer, JD ;
Stukel, TA ;
Siewers, AE ;
Goodney, PP ;
Wennberg, DE ;
Lucas, FL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (22) :2117-2127
[3]   Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer [J].
Darby, Sarah C. ;
Ewertz, Marianne ;
McGale, Paul ;
Bennet, Anna M. ;
Blom-Goldman, Ulla ;
Bronnum, Dorthe ;
Correa, Candace ;
Cutter, David ;
Gagliardi, Giovanna ;
Gigante, Bruna ;
Jensen, Maj-Britt ;
Nisbet, Andrew ;
Peto, Richard ;
Rahimi, Kazem ;
Taylor, Carolyn ;
Hall, Per .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) :987-998
[4]   Evaluation of Treatment Benefit in Journal of Clinical Oncology [J].
Goodwin, Pamela J. ;
Ballman, Karla V. ;
Small, Eric J. ;
Cannistra, Stephen A. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (09) :1123-1124
[5]   Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer [J].
Hershman, Dawn ;
Hall, Michael J. ;
Wang, Xiaoyan ;
Jacobson, Judith S. ;
McBride, Russell ;
Grann, Victor R. ;
Neugut, Alfred I. .
CANCER, 2006, 107 (11) :2581-2588
[6]   Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: a population-based study [J].
Kankesan, J. ;
Shepherd, F. A. ;
Peng, Y. ;
Darling, G. ;
Li, G. ;
Kong, W. ;
Mackillop, W. J. ;
Booth, C. M. .
CURRENT ONCOLOGY, 2013, 20 (01) :30-37
[7]   Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer [J].
Keating, Nancy L. ;
O'Malley, A. James ;
Smith, Matthew R. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4448-4456
[8]   Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration [J].
Landrum, Mary Beth ;
Keating, Nancy L. ;
Lamont, Elizabeth B. ;
Bozeman, Samuel R. ;
McNeil, Barbara J. .
CANCER, 2012, 118 (13) :3345-3355
[9]   Impact on survival of time from definitive surgery to initiation of adjuvant chemotherapy for early-stage breast cancer [J].
Lohrisch, Caroline ;
Paltiel, Charles ;
Gelmon, Karen ;
Speers, Caroline ;
Taylor, Suzanne ;
Barnett, Jeff ;
Olivotto, Ivo A. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (30) :4888-4894
[10]   Reporting of Serious Adverse Drug Reactions of Targeted Anticancer Agents in Pivotal Phase III Clinical Trials [J].
Seruga, Bostjan ;
Sterling, Lynn ;
Wang, Lisa ;
Tannock, Ian F. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (02) :174-185
12